Home
>
US Stocks
>
Denali Therapeutics Inc
Denali Therapeutics Inc
DNLI

Denali Therapeutics Inc (DNLI)

$47.710.19%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$47.5
Today Low/High$47 / $48.52
52 Week Low/High$42.09 / $93.94
P/E ratio103.1
Market Cap$5.79B

Company Details

Denali Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB) for neurodegenerative diseases. Denali pursues new treatments by rigorously assessing genetically validated targets, engineering delivery across the BBB and guiding development through biomarkers that demonstrate target and pathway engagement. Denali is based in South San Francisco.
OrganisationDenali Therapeutics Inc
HeadquatersSouth San Francisco, California, US
Employees291
IndustryHealth Technology
CEORyan Watts

Discover more

Frequently Asked Questions

What is Denali Therapeutics Inc (DNLI) share price today?

Can Indians buy Denali Therapeutics Inc (DNLI) shares?

How can I buy Denali Therapeutics Inc (DNLI) shares from India?

Can Fractional shares of Denali Therapeutics Inc (DNLI) be purchased?

What are the documents required to start investing in Denali Therapeutics Inc (DNLI) stocks?

We are a SEBI registered investement advisor